SL
Stella Diagnostics Inc.
SLDX · OTC
$0.01 +0.00% (+$0.00)
Market Cap $790.2K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.01
24.1% upside
Current Price
$0.0081
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SLDX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/S 0.47x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 21.65%
Net margin 258.33%
Op. margin 243.70%
Quality
79 /100
Excellent ROIC 27.71%
ROA 3,848.90%
Asset turnover 14.90x
Debt
0 /100
High Current ratio 0.00x
Int. coverage -16.65x
Debt/Equity N/A
Stability
19 /100
Unstable Beta -0.21x
EPS volatility 198.13%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SLDX
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
David Seaburg
Employees
2
Headquarters
Salt Lake City